Ian Bolland caught up with the team at Insulet to find out more about Omnipod an insulin delivery system which a tubeless device that can provide three days of non-stop insulin delivery, and the app associated with it.
Give us a bit of background on Omnipod where did the idea come from?
Insulet, maker of the Omnipod insulin delivery system is headquartered in Massachusetts, and is an medical device company dedicated to simplifying the lives of people with diabetes through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its intuitively simple, wearable design, the disposable, waterproof Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. The Omnipod system actually came to be because a dad with a son newly diagnosed with diabetes said there has to be a better way to manage this disease. He sketched it out on the back of a napkin on a flight from California back to Boston almost 20 years ago. That same innovative approach has remained with the company ever since and is woven into the companys fabric and culture.
Who did you work with to bring the product to life?
Many passionate engineers, scientists, entrepreneurs, business men and women, and those with diabetes or impacted by diabetes in some way helped bring the Omnipod system to life.
What kind of material is the pod made out of?
The Pod is made out of durable medical grade materials and is made up of 72 individual components that all co-exist under the hood of the Pod. We work with many materials vendors locally and across the globe.
How do you wear the pod?
The Pod adheres to the body with a medical grade adhesive and can be placed anywhere a person may give themselves an insulin injection. Popular and FDA-approved sites include back of the arms, lower back/buttocks, thigh, and abdomen. The Pod is also fully waterproof which further simplifies life because there is no need to disconnect for water activities like swimming or bathing like you would with a traditional tubed insulin pump.
How does it actually help manage a persons insulin?
The Pod is worn on the body with no attachment to the hand-held controller (Personal Diabetes Manger, PDM). The Pod will deliver background basal insulin regardless of PDM location once programmed. The PDM is commonly carried in a separate carry case with all other supplies, kept in a gym bag, a locker, with the school nurse, in a purse, etc. Approximately 15 minutes before eating a meal or snack, a person would then use the PDM to deliver a mealtime bolus dose of insulin based on the amount of carbohydrates they are about to consume.
What happens after the three days of non-stop insulin delivery? Does it need topping up in some way?
The Pod has an automatic shut-off after 72 hours. There is a warning alarm to alert a user that they are approaching their 72-hour auto-shut off, at which point a person would deactivate their used Pod and activate a new Pod.
Give us an idea into the app behind it what kind of features does it have?
The Omnipod Display app allows for a convenient display of PDM data on the users iOS smartphone including; Pod status, insulin therapy history, and alarms, as well as a Find My PDM feature. The Omnipod Display app allows users to manage their diabetes with discretion and provides the ability to check their PDM dashboards from their personal mobile devices. Users may also invite up to 12 people to view their PDM data using the Omnipod View app.
The Omnipod View app provides caregivers and family members the ability to remotely monitor Omnipod Dash System data for their loved ones. The same Omnipod Dash System data that is displayed on a smartphone can be viewed on one or more additional smartphones remotely to stay informed and help manage loved ones diabetes. It also provides caregivers with important information such as last bolus, insulin on board, and any recent alerts.
The Omnipod Display app and Omnipod View app iOS widgets, which can be accessed by swiping right from the home screen, can be configured next to the Dexcom Continuous Glucose Monitoring (CGM) G6 app iOS widget, providing an easy view of PDM and CGM data on a single smartphone screen.
Bret Christensen, chief commercial officer, said: The Omnipod Dash mobile apps and widget capability are the first of their kind when it comes to monitoring insulin pump data and we are excited to bring this combined view of insulin delivery and Dexcom CGM data to our users. People look at their mobile phone countless times throughout the day and now Omnipod Dash users are able to conveniently and discreetly check their diabetes status or that of their loved ones', in order to stay well-informed, help make diabetes management decisions, and make diabetes a smaller part of life.
How secure is any data that is captured by it?
The Omnipod System is an FDA-regulated medical device and has to be secure and it received ISO 27001 certification of its Omnipod DASH System in November 2018.
Around that same time, the Omnipod DASH system also receivedDTSec (Diabetes Technology Societys) Cybersecurity Standard for Connected Diabetes Device Security certification.Insuletis the only insulin pump company to have both certifications.
DTSec leverages ISO/IEC 15408 to provide a framework for risk-based, multi-stakeholder definition of security requirements. The Omnipod DASH System, Insulets next-generation platform, was designed to be the foundation for the companys future innovation. With the ISO 27001 and DTSec certifications, the Omnipod DASH System is now globally recognised for incorporating the highest standards for information and cyber security and safety, including secure data transfer between the Pod and the personal diabetes manager (PDM), as well as secure cloud storage.
Insulet CEO, Shacey Petrovic, added: With last years launch of Omnipod Dash we created our online training program for DASH customers transitioning from Omnipod. This enables users to get started with online training without the need to leave home or meet with a clinician for support. Thanks to Dashs simplicity, this web-based training has been a success and today it is being used extensively to support thousands of users and, in fact, many users transitioning from Omnipod to Omnipod Dash just rely on the intuitive user interface which provides step by step instructions to get started. These tools were created to support effective scaling of our business and have proven to be exceptionally helpful in our current environment.
Read the rest here:
How a tubeless device provides three days of non-stop insulin delivery - Med-Tech Innovation
- This 'itchy' symptom is an early sign of diabetes that people often miss; know more about it - The Times of India - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - ABC News - February 7th, 2025
- Incidence of type 2 diabetes and metabolic syndrome by Occupation 10-Year follow-up of the Gutenberg Health Study - BMC Public Health - February 7th, 2025
- Abbotts Above the Bias Film Reveals Misconceptions Can Impact Diabetes Care - MultiVu - February 7th, 2025
- Q&A: Diabetes care for the aging population in the digital age - Medical Xpress - February 7th, 2025
- The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes - Nature.com - February 7th, 2025
- Nanoparticle Therapy has Potential to Reprogram the Immune System in Type 1 Diabetes - Managed Healthcare Executive - February 7th, 2025
- Muscle quality index is correlated with insulin resistance and type 2 diabetes mellitus: a cross-sectional population-based study - BMC Public Health - February 7th, 2025
- Assessing type-2 diabetes risk based on the Indian diabetes risk score among adults aged 45 and above in India - Nature.com - February 7th, 2025
- Single-cell atlas of human pancreatic islet and acinar endothelial cells in health and diabetes - Nature.com - February 7th, 2025
- Sugary Drinks Fuel Millions of Diabetes and CVD Cases - Medscape - February 7th, 2025
- 1 in 5 UK adults estimated to have diabetes in new record high - Euronews - February 7th, 2025
- New, increasingly widely used diabetes medication may have additional health benefits for older adults - Medical Xpress - February 7th, 2025
- Patients using diabetes apps can miss critical alerts. Heres how to make sure youre getting them - Canon City Daily Record - February 7th, 2025
- Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024 - News-Press Now - February 7th, 2025
- Does wearing a continuous glucose monitor help people without diabetes? We asked experts. - Popular Science - February 7th, 2025
- What is prediabetes and what can you do to stop it? - The Independent - February 7th, 2025
- Diabetes symptoms: 6 high blood sugar warning signs that show on hand and feet - India.com - February 7th, 2025
- The #1 Habit for Better Heart Health If You Have Diabetes, According to Experts - EatingWell - February 7th, 2025
- 'Fix Broken Food System!' Government Urged as Study Says 1 in 5 Brits Affected by Diabetes - Men's Health UK - February 7th, 2025
- World Diabetes Day 2024 - World Health Organization (WHO) - December 6th, 2024
- The WHO Global Diabetes Compact - December 6th, 2024
- Diabetes - World Health Organization (WHO) - December 6th, 2024
- Kumamoto University researchers discover groundbreaking antidiabetic compound - EurekAlert - December 6th, 2024
- Med's David Kaelber comments on GLP-1 agonists, which provide benefits like managing diabetes and weight loss - The Daily | Case Western Reserve... - December 6th, 2024
- Jordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes Screening - Verywell Health - December 6th, 2024
- There's A Tasty Food That May Reduce Your Risk Of Developing Type 2 Diabetes, Study Shows - HuffPost - December 6th, 2024
- Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression - Medpage Today - December 6th, 2024
- GLP-1 Medications Associated with Reduced Likelihood of Dementia Compared to Other Diabetic Meds - Epic Research - December 6th, 2024
- Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News - December 6th, 2024
- Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal - December 6th, 2024
- New Study Teases Out Chocolate and Diabetes Connection - Medpage Today - December 6th, 2024
- Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com - December 6th, 2024
- Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN - December 6th, 2024
- Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |... - December 6th, 2024
- I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN - December 6th, 2024
- Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio - December 6th, 2024
- This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV - December 6th, 2024
- New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily - December 6th, 2024
- Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good - December 6th, 2024
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024
- Early vs Late Fast Window: Is One More Effective? - Medscape - September 13th, 2024
- Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU - September 13th, 2024
- Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek - September 13th, 2024
- Beds and Herts patients to be re-tested in diabetes results error - BBC.com - September 13th, 2024
- This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times - September 13th, 2024
- Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health - September 13th, 2024
- Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian - September 13th, 2024
- Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal - September 13th, 2024
- Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio - September 13th, 2024
- Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News - September 13th, 2024
- Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation - September 13th, 2024
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire - September 13th, 2024
- Dining with Diabetes workshops offered - The Courier-Express - September 13th, 2024
- Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net - September 13th, 2024
- The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The... - September 13th, 2024
- Artificial pancreas shows promise in people with type 1 diabetes on kidney dialysis - MSN - September 13th, 2024
- How an Indian executive battled flesh-eating disease and diabetes, and won - South China Morning Post - September 13th, 2024
- India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - PR Newswire - September 13th, 2024
- Why this diabetes drug may be the answer to NASA search for radiation protection - Texas Public Radio - September 13th, 2024
- The National Association of Chain Drug Stores and the American Diabetes Association Promote Nutrition Security and its Role in Preventing and Managing... - September 13th, 2024